
New research is paving the way for the development of innovative drugs that restore antibiotic susceptibility in antibiotic-resistant superbugs such as Klebsiella pneumoniae, a main cause of fatal lung and bloodstream infections worldwide. Researchers at the University of Copenhagen and Ross University School have discovered a new way to restore antibiotic susceptibility in multidrug-resistant (MDR) Klebsiella pneumoniae and Escherichia coli strains. The results of this research have recently been published in two scientific journals, Scientific Reports and Antimicrobial Agents and Chemotherapy, which are published by Nature Publishing Group and the American Society for Microbiology, respectively.












